menu
    • menu

    Company profile for Neuropore Therapies

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neuropore Therapies (NPT) Inc. is a San Diego, California based biopharmaceutical company developing novel, small molecule therapeutics for the treatment of neurodegenerative disorders. The approaches being taken by Neuropore Therapies target the core pathological processes underlying these disorders, including the intracellular accumulation of neurotoxic misfolded proteins and the associated chronic and maladaptive neuroinfl...
    Neuropore Therapies (NPT) Inc. is a San Diego, California based biopharmaceutical company developing novel, small molecule therapeutics for the treatment of neurodegenerative disorders. The approaches being taken by Neuropore Therapies target the core pathological processes underlying these disorders, including the intracellular accumulation of neurotoxic misfolded proteins and the associated chronic and maladaptive neuroinflammation that may both initiate and then drive progressive neurodegeneration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neuropore TherapiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10835 Road to the Cure, Suite 230 San Diego, CA 92121
    Telephone
    Telephone
    (858) 273-1831
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neuropore.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neuropore-therapies-inc.
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neuropore Therapies Awarded $4.8M Grant from The Michael J. Fox Foundation
    Neuropore Therapies Awarded $4.8M Grant from The Michael J. Fox Foundation

    19 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220419005052/en

    BUSINESSWIRE
    19 Apr 2022
    Share Share
    Neuropore Therapies Receives $20 M (USD) Milestone Payment Under Collaboration
    Neuropore Therapies Receives $20 M (USD) Milestone Payment Under Collaboration

    17 May 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210517005039/en/Neuropore-Therapies-Receives-20-Million-USD-Milestone-Payment-Under-Collaboration-and-License-Agreement-with-UCB

    BUSINESSWIRE
    17 May 2021
    Share Share
    Neuropore Therapies Licenses Autophagy Modulators to Global Cancer Technology
    Neuropore Therapies Licenses Autophagy Modulators to Global Cancer Technology

    29 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200929005053/en

    BUSINESSWIRE
    29 Sep 2020
    Share Share
    Neuropore Therapies Receives $500,000 Grant from The ALS Association
    Neuropore Therapies Receives $500,000 Grant from The ALS Association

    17 Feb 2020

    // FINANCE

    https://finance.yahoo.com/news/neuropore-therapies-receives-500-000-130100803.html

    FINANCE
    17 Feb 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search